Mint Tower Capital Management’s Kite Pharma, Inc. KITE Stock Holding History
Bought
Maintained
Sold
Mint Tower Capital Management's KITE Position: Q4 2017 in Review
Mint Tower Capital Management sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 5,000 shares — an estimated $899K sold.
Mint Tower Capital Management first reported a position in KITE in Q3 2017 and held it in 1 quarter. The position peaked at $899K in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.
- Mint Tower Capital Management reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
- Mint Tower Capital Management sold 5,000 Kite Pharma, Inc. shares in Q4 2017, an estimated $899K.
- Mint Tower Capital Management first reported a position in Kite Pharma, Inc. in Q3 2017 and held it in 1 quarter.
- Mint Tower Capital Management's Kite Pharma, Inc. position peaked at $899K in Q3 2017.
- 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.
Based on Mint Tower Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.